PainReform Ltd. Post Operative Pain Management Investor Presentation 2021

PainReform Ltd. is a biopharmaceutical company developing PRF-110, a drug candidate for post-operative pain management. The presentation outlines the company's forward-looking strategy, experienced management team with deep biotech and pharmaceutical backgrounds, and development pipeline focused on addressing post-operative pain treatment.